These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
181 related items for PubMed ID: 16203977
21. Monoclonal antibodies that bind to the core of fusion-active glycoprotein 41. Chen CH, Greenberg ML, Bolognesi DP, Matthews TJ. AIDS Res Hum Retroviruses; 2000 Dec 10; 16(18):2037-41. PubMed ID: 11153086 [Abstract] [Full Text] [Related]
26. The complex antigenicity of a small external region of the C-terminal tail of the HIV-1 gp41 envelope protein: a lesson in epitope analysis. Dimmock NJ. Rev Med Virol; 2005 Nov 18; 15(6):365-81. PubMed ID: 16106492 [Abstract] [Full Text] [Related]
27. Quaternary protein mimetics of gp41 elicit neutralizing antibodies against HIV fusion-active intermediate state. Sadler K, Zhang Y, Xu J, Yu Q, Tam JP. Biopolymers; 2008 Nov 18; 90(3):320-9. PubMed ID: 18338371 [Abstract] [Full Text] [Related]
28. Structural basis of enhanced binding of extended and helically constrained peptide epitopes of the broadly neutralizing HIV-1 antibody 4E10. Cardoso RM, Brunel FM, Ferguson S, Zwick M, Burton DR, Dawson PE, Wilson IA. J Mol Biol; 2007 Feb 02; 365(5):1533-44. PubMed ID: 17125793 [Abstract] [Full Text] [Related]
29. Monoclonal antibodies to HTLV-III451 gp41: delineation of an immunoreactive conserved epitope in the transmembrane region of divergent isolates of HIV-1. Veronese FD, Rahman R, Kalyanaraman VS, Pal R, Lusso P, Tritch R, Petteway S, Gallo RC, Sarngadharan MG. AIDS Res Hum Retroviruses; 1989 Oct 02; 5(5):479-86. PubMed ID: 2480151 [Abstract] [Full Text] [Related]
30. Neutralizing epitopes in the membrane-proximal region of HIV-1 gp41: genetic variability and co-variation. Dong XN, Chen YH. Immunol Lett; 2006 Aug 15; 106(2):180-6. PubMed ID: 16859756 [Abstract] [Full Text] [Related]
32. An alternative conformation of the gp41 heptad repeat 1 region coiled coil exists in the human immunodeficiency virus (HIV-1) envelope glycoprotein precursor. Mische CC, Yuan W, Strack B, Craig S, Farzan M, Sodroski J. Virology; 2005 Jul 20; 338(1):133-43. PubMed ID: 15950253 [Abstract] [Full Text] [Related]
33. Lipid modulation of membrane-bound epitope recognition and blocking by HIV-1 neutralizing antibodies. Huarte N, Lorizate M, Kunert R, Nieva JL. FEBS Lett; 2008 Nov 12; 582(27):3798-804. PubMed ID: 18930052 [Abstract] [Full Text] [Related]
34. Immunogenicity of a chimeric hepatitis A virus (HAV) carrying the HIV gp41 epitope 2F5. Kusov YY, Zamjatina NA, Poleschuk VF, Michailov MI, Morace G, Eberle J, Gauss-Müller V. Antiviral Res; 2007 Feb 12; 73(2):101-11. PubMed ID: 17014915 [Abstract] [Full Text] [Related]